AbbVie posted higher fourth-quarter revenue on the back of growth from its immunology portfolio, led by arthritis and Crohn’s disease drugs Skyrizi and Rinvoq.
Source link
AbbVie Revenue Rises on Immunology Growth
Date:
More like thisRelated
Starbucks Reveals Large Chair + New Mugs to Create ‘Third Place’
Starbucks is banking on everyday household items in hopes...
European Gas Prices Extend Gains on LNG Supply Fears
European natural-gas prices extended gains after top LNG...
Transfer rumors, news: Wrexham want Robertson if Premier League dream succeeds
Liverpool left back Andy Robertson is on the agenda...
Canada and Australia leaders urge war de-escalation, but agree Iran can’t get nuclear weapons
MELBOURNE, Australia -- The Canadian and Australian prime ministers...